Search Results - Eefting, Matthias

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion

    Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion by Eefting, Matthias, de Wreede, Liesbeth C, Halkes, Constantijn J M, von dem Borne, Peter A, Kersting, Sabina, Marijt, Erik W A, Veelken, Hendrik, Putter, Hein, Schetelig, Johannes, Falkenburg, J H Frederik

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation

    Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell trans... by Eefting, Matthias, von dem Borne, Peter A, de Wreede, Liesbeth C, Halkes, Constantijn J M, Kersting, Sabina, Marijt, Erik W A, Veelken, Hendrik, Falkenburg, Jh Frederik

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

    Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib by Ammatuna, Emanuele, Eefting, Matthias, van Lom, Kirsten, Kavelaars, François F., Valk, Peter J. M., Touw, Ivo P.

    Published in Annals of hematology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2

    Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2 by Pont, Margot J, van der Lee, Dyantha I, van der Meijden, Edith D, van Bergen, Cornelis A M, Kester, Michel G D, Honders, Maria W, Vermaat, Martijn, Eefting, Matthias, Marijt, Erik W A, Kielbasa, Szymon M, Hoen, Peter A C 't, Falkenburg, J H Frederik, Griffioen, Marieke

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

    Erratum to: Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib by Ammatuna, Emanuele, Eefting, Matthias, van Lom, Kirsten, Kavelaars, François G., Valk, Peter J. M., Touw, Ivo P.

    Published in Annals of hematology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Characteristics and outcomes of patients with a haematological malignancy admitted to the intensive care unit for a neurological event

    Characteristics and outcomes of patients with a haematological malignancy admitted to the intensive care unit for a neurological event by Riedijk, Martiene, van den Bergh, Walter M, van Vliet, Maarten, Kusadasi, Nuray, Span, Lambert R F, Tuinman, Pieter R, Arbous, M Sesmu, Müller, Marcella C A

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  7. 7
    Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program

    Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program by Huls, Geert A, van der Helm, Lieke H., Alhan, Canan, Wijermans, P.W., van Marwijk Kooy, Marinus, Schaafsma, Martijn R., Biemond, Bart J, Beeker, Aart, Hoogendoorn, Mels, van Rees, Bastiaan P., de Weerdt, Okke, Wegman, Jurgen, Libourel, Eduard J, Luykx-de Bakker, Sylvia A., Minnema, Monique C., Brouwer, Rolf, Croon-de Boer, Fransien, Eefting, Matthias, Jie, Kon-Siong G., van der Loosdrecht, Arjan A., Koedam, Jan, Veeger, Nic J.G.M., Vellenga, Edo

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Integrated whole genome and transcriptome analysis identified a therapeutic minor histocompatibility antigen encoded by an alternative ITGB2 transcript

    Integrated whole genome and transcriptome analysis identified a therapeutic minor histocompatibility antigen encoded by an alternative ITGB2 transcript by Pont, Margot J, van der Lee, Dyantha, van der Meijden, Edith, van Bergen, Cornelis, Kester, Michel, Honders, Maria, Vermaat, Martijn, Eefting, Matthias, Marijt, Erik, Kielbasa, Szymon, 't Hoen, Peter-Bram, Falkenburg, Frederik, Griffioen, Marieke

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

    Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib by Ammatuna, Emanuele, Eefting, Matthias, van Lom, Kirsten, Kavelaars, François G, Kavelaars, François F, Valk, Peter J M, Touw, Ivo P

    Published in Annals of hematology
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: